Stay updated on Nivolumab vs Combo Immunotherapy in Non-Clear Cell RCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Combo Immunotherapy in Non-Clear Cell RCC Clinical Trial page.

Latest updates to the Nivolumab vs Combo Immunotherapy in Non-Clear Cell RCC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedSite-wide maintenance updates include a new Revision: v3.4.2 and the removal of a prior government funding/operating status notice. These changes do not modify the study details, eligibility criteria, outcomes, or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a government funding lapse notice and updated the site revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedAdditions include showing the glossary and new footer metadata: 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Deletions remove the older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. No substantive changes to study details or navigation are indicated.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations are reorganized with a new top-level 'Locations' heading and updated state listings (New South Wales, Queensland, South Australia, Victoria, Western Australia). The HHS Vulnerability Disclosure footer link was removed and revision numbers updated from v3.3.2 to v3.3.3.SummaryDifference0.6%

- Check92 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the site, with no visible changes to the Study Details page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Nivolumab vs Combo Immunotherapy in Non-Clear Cell RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Combo Immunotherapy in Non-Clear Cell RCC Clinical Trial page.